Table 1.
Group 1 | Group 2 | Group 3 | |
---|---|---|---|
MMP-3 expression (%) | 42.5 ± 21.0 (5–80) | 14.4 ± 19.8 (0–50) | 3.6 ± 4.1 (0–10) |
P = 0.001 | P = 0.429 | ||
OARSI histopathology scores | 9.4 ± 3.9 (4–16) | 5.1 ± 3.6 (1–9) | – |
P = 0.004 | P < 0.001 |
Group 1 | Group 2 | Group 3 | |
---|---|---|---|
MMP-3 expression (%) | 42.5 ± 21.0 (5–80) | 14.4 ± 19.8 (0–50) | 3.6 ± 4.1 (0–10) |
P = 0.001 | P = 0.429 | ||
OARSI histopathology scores | 9.4 ± 3.9 (4–16) | 5.1 ± 3.6 (1–9) | – |
P = 0.004 | P < 0.001 |